Charles Schwab Investment Management »

Candel Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $290k 47k 6.20

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Bridgeway Capital Management
Citadel Advisors
Mml Investors Services
Susquehanna International
HB Wealth Management
Bank of New York Mellon
Bank of America Corporation
Charles Schwab Investment Management
Cubist Systematic Strategies

View all funds holding Candel Therapeutics